Warner Bros. Discovery
Patents, Design & Utilities

Last updated:

List of all Warner Bros. Discovery patents 102 in total

Status Patent
Application
Utility: COMPOUND AS PORCUPINE INHIBITOR AND USE THEREOF External link
Filling date: 7 Sep 2025 Issue date: 8 Sep 2022
Grant
Utility: Identification of selected spectrum antibiotics External link
Filling date: 7 Sep 2025 Issue date: 30 Aug 2022
Application
Utility: SGLT2/DPP4 INHIBITOR AND APPLICATION THEREOF External link
Filling date: 7 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: BICYCLIC COMPOUND AS RIP-1 KINASE INHIBITOR AND APPLICATION THEREOF External link
Filling date: 7 Sep 2025 Issue date: 4 Aug 2022
Application
Utility: CRYSTAL FORM OF C-MET/AXL INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: IMIDAZOPYRIDINE COMPOUND AS IRAK4 INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 21 Jul 2022
Grant
Utility: Heterocyclic compound as CSF-1R inhibitor and use thereof External link
Filling date: 7 Sep 2025 Issue date: 12 Jul 2022
Grant
Utility: Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors External link
Filling date: 7 Sep 2025 Issue date: 5 Jul 2022
Application
Utility: MACROCYCLIC DERIVATIVES ACTING AS XIA FACTOR INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: NITROGEN-CONTAINING SPIRO DERIVATIVE AS RET INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: CRYSTAL FORM OF EGFR INHIBITOR AND PREPARATION METHOD THEREOF External link
Filling date: 7 Sep 2025 Issue date: 23 Jun 2022
Grant
Utility: Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method therefor External link
Filling date: 7 Sep 2025 Issue date: 7 Jun 2022
Grant
Utility: Asset search and discovery system using graph data structures External link
Filling date: 7 Sep 2025 Issue date: 31 May 2022
Grant
Utility: Benzopyrazole compound used as RHO kinase inhibitor External link
Filling date: 7 Sep 2025 Issue date: 31 May 2022
Application
Utility: GLUCOSIDE DERIVATIVE THAT ACTS AS SGLT1 INHIBITOR AND APPLICATION THEREOF External link
Filling date: 7 Sep 2025 Issue date: 19 May 2022
Grant
Utility: Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor External link
Filling date: 7 Sep 2025 Issue date: 10 May 2022
Grant
Utility: Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same External link
Filling date: 7 Sep 2025 Issue date: 3 May 2022
Grant
Utility: Tricyclic furan-substituted piperidinedione compound External link
Filling date: 7 Sep 2025 Issue date: 3 May 2022
Grant
Utility: Prostacyclin receptor agonist External link
Filling date: 7 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Salt and crystal form of modified andrographolide compound and preparation method thereof External link
Filling date: 7 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Biomarkers of autism spectrum disorder External link
Filling date: 7 Sep 2025 Issue date: 8 Mar 2022
Application
Utility: Pyrazole Compounds As LSD1 Inhibitors And Applications Thereof External link
Filling date: 7 Sep 2025 Issue date: 3 Mar 2022
Grant
Utility: Compound as GLS1 inhibitor External link
Filling date: 7 Sep 2025 Issue date: 22 Feb 2022
Application
Utility: ESTROGEN RECEPTOR ANTAGONIST External link
Filling date: 7 Sep 2025 Issue date: 3 Feb 2022
Grant
Utility: Protein kinase inhibitors External link
Filling date: 7 Sep 2025 Issue date: 1 Feb 2022
Grant
Utility: Methods and systems for searching and indexing virtual environments External link
Filling date: 7 Sep 2025 Issue date: 1 Feb 2022
Grant
Utility: Substituted 1,3,4-thiadiazoles as GLS1 inhibitors External link
Filling date: 7 Sep 2025 Issue date: 25 Jan 2022
Grant
Utility: Quinolino-pyrrolidin-2-one derivative and application thereof External link
Filling date: 7 Sep 2025 Issue date: 25 Jan 2022
Application
Utility: TRICYCLIC COMPUND AS CRTH2 INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 30 Dec 2021
Grant
Utility: Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof External link
Filling date: 7 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Substituted ureas and methods of making and using same External link
Filling date: 7 Sep 2025 Issue date: 14 Dec 2021
Grant
Utility: Crystal form and salt form of pyridone compound and preparation method therefor External link
Filling date: 7 Sep 2025 Issue date: 14 Dec 2021
Application
Utility: QUINOLINO-PYRROLIDIN-2-ONE DERIVATIVE AND APPLICATION THEREOF External link
Filling date: 7 Sep 2025 Issue date: 9 Dec 2021
Grant
Utility: S1P1 agonist and application thereof External link
Filling date: 7 Sep 2025 Issue date: 7 Dec 2021
Grant
Utility: Peripherally-restricted dual-acting kappa and delta opioid agonist for analgesia in pain states involving the inflammatory response External link
Filling date: 7 Sep 2025 Issue date: 30 Nov 2021
Grant
Utility: Biphenyl compound as CCR2/CCR5 receptor antagonist External link
Filling date: 7 Sep 2025 Issue date: 26 Oct 2021
Application
Utility: ISOTHIAZOLOPYRIMIDINONES, PYRAZOLOPYRIMIDINONES, AND PYRROLOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS External link
Filling date: 7 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS External link
Filling date: 7 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: PYRROLO[2,1-F][1,2,4]TRIAZINE DERIVATIVES SERVING AS SELECTIVE HER2 INHIBITORS AND APPLICATION THEREOF External link
Filling date: 7 Sep 2025 Issue date: 21 Oct 2021
Grant
Utility: CXCR2 antagonist External link
Filling date: 7 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: [1,2,4]triazolo[1,5-c]pyrimidine derivative as A.sub.2A receptor inhibitor External link
Filling date: 7 Sep 2025 Issue date: 14 Sep 2021
Application
Utility: ISOTHIAZOLO[5,4-D]PYRIMIDINE COMPOUND AS IRAK4 INHIBITOR External link
Filling date: 7 Sep 2025 Issue date: 2 Sep 2021
Application
Utility: PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) External link
Filling date: 7 Sep 2025 Issue date: 12 Aug 2021
Grant
Utility: Combination therapies with disulfiram External link
Filling date: 7 Sep 2025 Issue date: 20 Jul 2021
Grant
Utility: Quinazoline compound for EGFR inhibition External link
Filling date: 7 Sep 2025 Issue date: 22 Jun 2021
Grant
Utility: Combination therapies with disulfiram External link
Filling date: 7 Sep 2025 Issue date: 15 Jun 2021
Application
Utility: Pyridone-Pyrimidine Derivative Acting As KRASG12C Mutein Inhibitor External link
Filling date: 7 Sep 2025 Issue date: 20 May 2021
Application
Utility: QUINAZOLINONES AND AZAQUINAZOLINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS External link
Filling date: 7 Sep 2025 Issue date: 6 May 2021
Grant
Utility: Crystal form of URAT1 inhibitor, and preparation method therefor External link
Filling date: 7 Sep 2025 Issue date: 4 May 2021
Grant
Utility: Alpha-cinnamide compounds and compositions as HDAC8 inhibitors External link
Filling date: 7 Sep 2025 Issue date: 27 Apr 2021

Showing 1 to 50 of 102 patents.